Conference item : Abstract
Microarray pathway analysis comparing baricitinib and adalimumab in moderate to severe rheumatoid arthritis patients, from a Phase 3 study
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 293.6KB, Terms of use)
-
- Publisher copy:
- 10.1002/art.40321
Authors
- Publisher:
- Wiley
- Journal:
- Arthritis & Rheumatology More from this journal
- Volume:
- 69
- Issue:
- S10
- Article number:
- 2866
- Publication date:
- 2017-09-27
- Acceptance date:
- 2017-06-13
- Event title:
- American College of Rheumatology’s 2017 Annual Meeting
- Event location:
- San Diego, CA, USA
- Event website:
- https://www.rheumatology.org/Annual-Meeting/Resources/General-Meeting-Information
- Event start date:
- 2017-11-03
- Event end date:
- 2017-11-08
- DOI:
- EISSN:
-
2326-5205
- ISSN:
-
2326-5191
- Language:
-
English
- Subtype:
-
Abstract
- Pubs id:
-
pubs:796710
- UUID:
-
uuid:deda2be4-f7a7-46e4-bec3-d5637654e0dd
- Local pid:
-
pubs:796710
- Source identifiers:
-
796710
- Deposit date:
-
2018-05-21
Terms of use
- Copyright holder:
- American College of Rheumatology
- Copyright date:
- 2017
- Rights statement:
- © 2017, American College of Rheumatology.
- Notes:
- This is the accepted manuscript version of the abstract. The final version is available online from Wiley at: https://doi.org/10.1002/art.40321
If you are the owner of this record, you can report an update to it here: Report update to this record